Biodelivery Sciences International Profit Margin

The latest profit margin for BDSI is 50.9% as of December 2021. That compares with 16.43% in the prior-year period — up 209.8% year over year. That is above the Healthcare sector average of 21.34%. Investors often review this figure alongside Biodelivery Sciences International's historical trend and sector peers before judging valuation or financial health.

Over the past year, BDSI's profit margin moved from 16.43% to 50.9% — a 209.8% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Biodelivery Sciences International's valuation or profitability profile.

Against Healthcare companies, BDSI currently prints 50.9% for profit margin, while the sector average sits near 21.34%. That is roughly 138.6% above the sector mean. Large gaps often invite a closer look at Biodelivery Sciences International's growth, margins, and balance sheet.

Profit Margin shows how effectively Biodelivery Sciences International converts resources into returns. At 50.9%, BDSI may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with 16.43% in the prior-year period — up 209.8% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.

After noting BDSI's profit margin (50.9%), review year-over-year change from 16.43%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.